Optimizing Recovery After Reverse Shoulder Arthroplasty With a Personalized Mobile Health Application
TRAPP
2 other identifiers
interventional
170
1 country
1
Brief Summary
Background: Mobile health (mHealth) - the use of medical applications in healthcare settings - include tools that can support self-management after surgery and thereby contribute to early postoperative recovery. Providing patients with timely and interactive information through mHealth is hypothesized to positively influence recovery after reverse shoulder arthroplasty (RSA). Aim: The aim of this study is to determine the effectiveness of interactive and personalized information and rehabilitation protocol with a mobile application compared to generic information and generic rehabilitation protocol (standard care) on postoperative recovery in patients undergoing primary RSA. Methods and analysis: A multicentre randomised controlled trial will be conducted in two Dutch hospitals. In total 170 patients undergoing elective, primary RSA will be included. Participants will be randomly allocated to one of the two groups on a 1:1 ratio. The intervention group will receive interactive postoperative information on a daily basis. The control group will receive standard care. The primary outcome is defined as functional recovery measured using the Oxford Shoulder Score (OSS) at 6 weeks. Secondary outcomes are: pain, physical functioning, quality of life, length of stay, complications, treatment satisfaction and app use. The between group difference will be analysed using linear mixed-effects regression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 5, 2024
CompletedFirst Posted
Study publicly available on registry
July 25, 2024
CompletedStudy Start
First participant enrolled
August 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
July 25, 2024
July 1, 2024
1.9 years
July 5, 2024
July 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative shoulder functioning
Shoulder functioning measured with the Oxford Shoulder Score
bssix weeks, three months and 1 year
Secondary Outcomes (6)
Shoulder pain
baseline, daily during the first 6 weeks, 3 months and 1 year
Shoulder disability
baseline, six weeks, three months and 1 year
Range of Motion of the Shoulder
baseline, six weeks, three months and 1 year
Satisfaction with the Application
six weeks, three months and 1 year
Readmission rate
1 year
- +1 more secondary outcomes
Study Arms (2)
Personalized rehabilitation program
EXPERIMENTALThe intervention group receives an interactive app that is different from the control is different from the control group in that it provides interactive and personalized information and a personalized rehabilitation program. Both the timing and the amount and nature of the exercises are personalized.
Standard care
ACTIVE COMPARATORThe control group will receive postoperative information and a rehabilitation program via the non-interactive application, which is current standard care
Interventions
Patients will receive interactive information via an mHealth application tailored to their needs and progress during the rehabilitation period after RSA.
Eligibility Criteria
You may qualify if:
- adults undergoing elective reverse shoulder arthroplasty
You may not qualify if:
- \) do not own or are not able to operate a smart device; 2) are scheduled for revision surgery; 3) have a fracture as primary diagnosis; 4) an additional muscle transfer needs to be performed; or 5) are unable to read and understand the Dutch language.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- VieCuri Medical Centrelead
- Anna ziekenhuiscollaborator
Study Sites (1)
VieCuri Medisch Centrum
Venlo, Limburg, 5912BL, Netherlands
Related Publications (1)
Crutsen JRW, Heerspink FOL, Kornuijt A, Ascencio J, van der Weegen W, Timmers T, Craamer C, van Raay JJAM, Hollman F, Janssen ERC. Optimizing recovery after reverse shoulder arthroplasty with a personalised mobile health application compared to generic digital information: a protocol of a multicentre randomised controlled trial. BMC Musculoskelet Disord. 2025 Jul 4;26(1):642. doi: 10.1186/s12891-025-08857-9.
PMID: 40616068DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Because the application relies on interaction between patient and clinical care team, both the patient and clinicians cannot be blinded. The researcher that will perform data analysis will be blinded to group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 5, 2024
First Posted
July 25, 2024
Study Start
August 1, 2024
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
July 25, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share
IPD may be requested through the contact person. Upon reasonable request these may be provided on a case by case basis.